LONGEVITY HEALTH HOLDINGS IN (XAGE) Stock Price, Forecast & Analysis
USA - NASDAQ:XAGE - US1429221294 - Common Stock
XAGE Key Statistics, Chart & Performance
The current stock price of XAGE is 2.32 USD. In the past month the price decreased by -3.33%.
XAGE Latest News, Press Relases and Analysis
XAGE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.59 | 410.48B | ||
| AMGN | AMGEN INC | 15.4 | 181.29B | ||
| GILD | GILEAD SCIENCES INC | 15.26 | 155.13B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.18 | 112.08B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.41 | 73.50B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 880.71 | 58.88B | ||
| INSM | INSMED INC | N/A | 40.84B | ||
| NTRA | NATERA INC | N/A | 28.04B | ||
| BIIB | BIOGEN INC | 10.01 | 24.56B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.67 | 21.10B | ||
| INCY | INCYTE CORP | 16.22 | 20.34B | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | 34.66 | 14.37B |
Related stock screener links
About XAGE
Company Profile
Longevity Health Holdings, Inc. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 15 full-time employees. The company went IPO on 2021-07-29. The firm has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity.
Company Info
LONGEVITY HEALTH HOLDINGS IN
2403 Sidney Street, Suite 300
Pittsburgh PENNSYLVANIA US
Employees: 15
Phone: 14128948248
LONGEVITY HEALTH HOLDINGS IN / XAGE FAQ
What does LONGEVITY HEALTH HOLDINGS IN do?
Longevity Health Holdings, Inc. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 15 full-time employees. The company went IPO on 2021-07-29. The firm has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity.
What is the stock price of LONGEVITY HEALTH HOLDINGS IN today?
The current stock price of XAGE is 2.32 USD. The price decreased by -15.33% in the last trading session.
What is the dividend status of LONGEVITY HEALTH HOLDINGS IN?
XAGE does not pay a dividend.
What is the ChartMill technical and fundamental rating of XAGE stock?
XAGE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the market capitalization of XAGE stock?
LONGEVITY HEALTH HOLDINGS IN (XAGE) has a market capitalization of 4.13M USD. This makes XAGE a Nano Cap stock.
Can you provide the ownership details for XAGE stock?
You can find the ownership structure of LONGEVITY HEALTH HOLDINGS IN (XAGE) on the Ownership tab.
XAGE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to XAGE.
XAGE Financial Highlights
Over the last trailing twelve months XAGE reported a non-GAAP Earnings per Share(EPS) of -8.52. The EPS increased by 66.55% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -193.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |